TickerKhojComparison · NSE · data 2026-11-02
Hikal Limited vs Sai Parenterals Limited
In plain words
Size: Hikal Limited is about 1.1 times the market value of Sai Parenterals Limited.
Return on equity: Sai Parenterals Limited 4.9% vs Hikal Limited -4%.
Debt to equity: Sai Parenterals Limited 0.96 vs Hikal Limited 0.57.
Differences in the numbers, not a recommendation of either stock.
Side by side
| HIKAL | SAIPARENT | |
|---|---|---|
| Price | ₹216.48 | ₹515.8 |
| Market cap | ₹2,601 cr | ₹2,302 cr |
| P/E | — | — |
| P/B | — | — |
| ROE | -4.0% | 4.9% |
| ROCE | 3.1% | 5.8% |
| Debt / equity | 0.57 | 0.96 |
| Operating margin | 3.8% | — |
| Dividend yield | 0.28% | 0.00% |
| Sales growth, 3 years (yearly) | -5.4% | 57.9% |
| Profit growth, 3 years (yearly) | — | 48.3% |
| 1-year return | -9.9% | 28.9% |
| Revenue, last 12 months | ₹1,735 cr | — |
| Net profit, last 12 months | ₹-34 cr | — |
| Latest quarter | Jun 2026 | Sept 2026 |
| Quarter net profit | ₹-7 cr | ₹11 cr |
| Quarter profit vs a year earlier | — | — |
| Promoter holding | 68.85% | 51.16% |
| Health check | Weak (1.1/10) | Strong (6.6/10) |
Common questions
Which earns a higher return on equity?
Sai Parenterals Limited (4.9% against -4.0%).
Which carries more debt?
Sai Parenterals Limited has the higher debt-to-equity ratio (0.96 against 0.57).